UNSPSC 51373001: Anazocine

This classification denotes an opioid receptor agonist with the molecular formula C16H23NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier K2S5VMM2SG, chemically known as 4-beta-methoxy-1-methyl-4-alpha-phenyl-3-alpha,5-alpha-propanopiperidine but generally known as anazocine, which bears US NIH Compound Identifier 27213. European Medicines Agency schedules Anazocine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05504MIG.

UNSPSC 51373001 Anazocine, a Commodity code, covers pharmaceutical products related to opioid antagonists and related drug compounds, though state and local governments soliciting under this code are actually procuring naloxone and drug deactivation systems to support emergency response and community health initiatives. The work encompasses acquisition of ready-to-use pharmaceutical products and related harm-reduction equipment, typically for distribution through public health departments, county health agencies, and community health facilities. Issuing bodies under this code include county health departments and special-purpose health districts focused on substance-abuse prevention and emergency medical response.

Seminole County, Florida represents the documented recent activity. Seminole County issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The IFB required electronic bid submission with all shipping and delivery costs included in the proposal; the original response deadline was July 26, 2023, at 2:00 pm. The contract carried a two-year initial term with a one-year renewal option, fixed-fee pricing structure, and potential FEMA funding with associated federal compliance requirements including the Clean Air Act and Federal Water Pollution Control Act. Vendors were required to provide drug-free workplace certification, E-Verify compliance, workers' compensation, commercial general liability, and professional liability insurance. The procurement included a three-month probationary period allowing Seminole County to terminate with or without cause.